A relationship between reduced occludin expression and unfavorable tumor phenotype or poor prognosis has earlier been reported for carcinomas of the breast [14], gallbladder [20], gastrointestinal tract [15,18], endometrial cancer [17] as well as squamous cell carcinomas of the esophagus [19]. The gene discussed is OCLN; the disease is endometrial cancer.